bepridil has been researched along with cetiedil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culliford, SJ; Ellory, JC; Horwitz, E; Nash, GB; Stone, PC; Stuart, J | 1 |
| Asakura, T; Reilly, MP | 1 |
| Blas, SD; Davis, FB; Davis, PJ; Dube, MP | 1 |
| Agre, P; Bennett, V; Virshup, D | 1 |
4 other study(ies) available for bepridil and cetiedil
| Article | Year |
|---|---|
Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
Topics: Anemia, Sickle Cell; Azepines; Bepridil; Calcium; Calcium Channel Blockers; Erythrocytes, Abnormal; Fendiline; Humans; In Vitro Techniques; Nitrendipine; Oxygen; Potassium Channels | 1992 |
Antisickling effect of bepridil.
Topics: Anemia, Sickle Cell; Antisickling Agents; Azepines; Bepridil; Erythrocytes; Humans; In Vitro Techniques; Pyrrolidines | 1986 |
Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.
Topics: Azepines; Bepridil; Calcium-Transporting ATPases; Calmodulin; Cell Membrane; Erythrocytes; Humans; Pyrrolidines; Thyroxine | 1987 |
Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Topics: Adult; Azepines; Bepridil; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Calmodulin; Calmodulin-Binding Proteins; Erythrocyte Membrane; Humans; Kinetics; Phosphoprotein Phosphatases; Pyrrolidines; Trifluoperazine; Vasodilator Agents | 1984 |